PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
lorlatinib Sensitive: C4 – Case Studies
|
lorlatinib Sensitive: C4 – Case Studies
|
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
FOLFIRINOX Resistant: C4 – Case Studies
|
FOLFIRINOX Resistant: C4 – Case Studies
|
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
PPFIBP1-ALK translocation + ALK G1202R + ALK V1180L
|
Pancreatic Ductal Adenocarcinoma
|
alectinib Resistant: C4 – Case Studies
|
alectinib Resistant: C4 – Case Studies
|